Guyasuta Investment Advisors’s Pfizer PFE Stock Holding History

Guyasuta Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Sell	113,231 -7,286	-6%	-$191K	0.14%	83
2026 Q1	$3.38M	Sell	120,517 -7,494	-6%	-$200K	0.2%	69
2025 Q4	$3.19M	Sell	128,011 -1,875	-1%	-$47.3K	0.18%	68
2025 Q3	$3.31M	Sell	129,886 -649	-0.5%	-$16K	0.19%	66
2025 Q2	$3.16M	Sell	130,535 -2,115	-2%	-$49.3K	0.19%	67
2025 Q1	$3.36M	Sell	132,650 -567	-0.4%	-$14.8K	0.22%	61
2024 Q4	$3.53M	Sell	133,217 -11,829	-8%	-$321K	0.22%	58
2024 Q3	$4.2M	Sell	145,046 -122,116	-46%	-$3.56M	0.26%	55
2024 Q2	$7.69M	Sell	267,162 -3,093	-1%	-$85.2K	0.57%	39
2024 Q1	$7.78M	Sell	270,255 -1,786	-0.7%	-$49.6K	0.56%	39
2023 Q4	$7.83M	Sell	272,041 -622,742	-70%	-$18.8M	0.57%	39
2023 Q3	$29.7M	Sell	894,783 -2,144	-0.2%	-$75.8K	2.3%	15
2023 Q2	$32.9M	Sell	896,927 -9,883	-1%	-$385K	2.43%	13
2023 Q1	$37M	Buy	906,810 +8,316	+0.9%	+$359K	2.86%	11
2022 Q4	$46M	Buy	898,494 +14,332	+2%	+$687K	3.63%	7
2022 Q3	$38.7M	Buy	884,162 +2,818	+0.3%	+$137K	3.34%	8
2022 Q2	$46.2M	Sell	881,344 -792	-0.1%	-$40.4K	3.61%	6
2022 Q1	$45.7M	Sell	882,136 -5,311	-0.6%	-$276K	3.14%	8
2021 Q4	$52.4M	Sell	887,447 -9,954	-1%	-$493K	3.43%	6
2021 Q3	$38.6M	Buy	897,401 +189	+0%	+$8.37K	2.75%	11
2021 Q2	$35.1M	Buy	897,212 +21,219	+2%	+$825K	2.53%	13
2021 Q1	$31.7M	Buy	875,993 +30,483	+4%	+$1.08M	2.48%	13
2020 Q4	$31.1M	Sell	845,510 -39,247	-4%	-$1.44M	2.6%	14
2020 Q3	$30.8M	Sell	884,757 -685	-0.1%	-$24K	2.86%	10
2020 Q2	$27.5M	Sell	885,442 -2,569	-0.3%	-$87.3K	2.82%	11
2020 Q1	$27.5M	Sell	888,011 -7,433	-0.8%	-$253K	3.3%	9
2019 Q4	$33.3M	Buy	895,444 +25,309	+3%	+$901K	3.23%	8
2019 Q3	$29.7M	Buy	870,135 +29,342	+3%	+$1.07M	3.07%	9
2019 Q2	$34.6M	Buy	840,793 +23,136	+3%	+$919K	3.59%	6
2019 Q1	$32.9M	Sell	817,657 -8,195	-1%	-$328K	3.67%	4
2018 Q4	$34.2M	Buy	825,852 +2,539	+0.3%	+$105K	4.22%	3
2018 Q3	$34.4M	Sell	823,313 -17,649	-2%	-$679K	3.67%	4
2018 Q2	$28.9M	Buy	840,962 +480	+0.1%	+$16.4K	3.32%	4
2018 Q1	$28.3M	Buy	840,482 +24,987	+3%	+$859K	3.31%	5
2017 Q4	$28M	Sell	815,495 -3,272	-0.4%	-$112K	3.18%	6
2017 Q3	$27.7M	Sell	818,767 -6,952	-0.8%	-$223K	3.35%	6
2017 Q2	$26.3M	Buy	825,719 +4,398	+0.5%	+$139K	3.16%	6
2017 Q1	$26.7M	Sell	821,321 -5,016	-0.6%	-$158K	3.22%	6
2016 Q4	$25.5M	Buy	826,337 +71,779	+10%	+$2.19M	3.29%	6
2016 Q3	$24.2M	Buy	754,558 +12,202	+2%	+$408K	3.09%	7
2016 Q2	$24.8M	Buy	742,356 +1,263	+0.2%	+$40.3K	3.32%	4
2016 Q1	$20.8M	Buy	741,093 +10,356	+1%	+$296K	2.9%	9
2015 Q4	$22.4M	Sell	730,737 -7,188	-1%	-$226K	3.15%	9
2015 Q3	$22M	Sell	737,925 -27,653	-4%	-$887K	3.2%	3
2015 Q2	$24.4M	Buy	765,578 +10,287	+1%	+$335K	3.23%	3
2015 Q1	$24.9M	Buy	755,291 +6,214	+0.8%	+$198K	3.35%	3
2014 Q4	$22.1M	Sell	749,077 -8,959	-1%	-$257K	2.98%	7
2014 Q3	$21.3M	Sell	758,036 -10,161	-1%	-$285K	2.96%	5
2014 Q2	$21.6M	Buy	768,197 +24,285	+3%	+$692K	2.86%	7
2014 Q1	$22.7M	Buy	743,912 +27,174	+4%	+$810K	3.23%	3
2013 Q4	$20.8M	Buy	716,738 +3,625	+0.5%	+$106K	3.04%	5
2013 Q3	$19.4M	Buy	713,113 +10,924	+2%	+$297K	3.1%	6
2013 Q2	$18.7M	Buy	+702,189	New	+$19.4M	3.05%	5

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Guyasuta Investment Advisors's PFE Position: Q2 2026 in Review

Guyasuta Investment Advisors reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $191K and leaving 113,231 shares worth $2.73M. The position accounts for 0.14% of the portfolio, ranked #83.

Guyasuta Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.4M in Q4 2021. 1,265 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Guyasuta Investment Advisors held 113,231 shares of Pfizer worth $2.73M as of Q2 2026.
Guyasuta Investment Advisors sold 7,286 Pfizer shares in Q2 2026, an estimated $191K.
Pfizer made up 0.14% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #83 holding.
Guyasuta Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Guyasuta Investment Advisors's Pfizer position peaked at $52.4M in Q4 2021.
1,265 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.